GlassScriptPhysician profile
Yuanyuan Zhang
NPI 1144546961
$5,480.01
in general payments reported to CMS, 2019-2025
32 companies · $715 in 2025
The $715 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $461 · 2021: $498 · 2022: $838 · 2023: $1,082 · 2024: $939 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,693 · Education: $42.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,693.28 |
| Education | $42.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $620.47 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Janssen Pharmaceuticals, INC | $600.57 | 2019-2024 | Xarelto |
| Amgen INC. | $558.42 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $524.98 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $513.11 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $440.82 | 2019-2024 | Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $316.54 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $264.51 | 2021-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.01 | 2022-2025 | Jardiance |
| Abbott Laboratories | $235.55 | 2019-2025 | Ensite, Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $220.64 | 2019-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $190.71 | 2019-2023 | |
| Esperion Therapeutics, INC. | $122.88 | 2021-2024 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $108.09 | 2019-2024 | Evkeeza |
| Boston Scientific Corporation | $85.26 | 2019-2025 | Bodyguardian |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $55.93 | 2024-2025 | |
| Lundbeck LLC | $47.43 | 2019-2020 | |
| Amarin Pharma, INC. | $42.85 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $35.90 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $33.38 | 2021-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $32.54 | 2019 | |
| Lilly USA, LLC | $26.02 | 2025 | Mounjaro, Zepbound |
| Heartflow, INC. | $24.06 | 2023 | Ffrct |
| Bayer Healthcare Pharmaceuticals INC. | $22.64 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $19.21 | 2024 | |
| Travere Therapeutics, INC. | $16.66 | 2019 | |
| Agepha Pharma Fz LLC | $16.65 | 2025 | Lodoco |
| Kiniksa Pharmaceuticals International, Plc | $15.77 | 2024 | Arcalyst |
| Medtronic, INC. | $15.73 | 2023 | Cobalt Dr Mri Surescan |
| Kowa Pharmaceuticals America, INC. | $14.87 | 2021 | |
| Medtronic Vascular, INC. | $13.05 | 2020 | |
| Acarix USA INC. | $8.76 | 2023 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuanyuan Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.